CASP3 and infection: Some residual caspase 3 activity remained in both Gambogic acid-treated cells (4%, Center, right) and LB-piVe-treated cells (11.7%), suggesting that caspase 3 was activated rapidly after infection and before Z-VAD-FMK treatment.